Ramya Krishna Vadlapatla
- Co-authors
- Aswani Dutt VadlapudiAshim K. MitraDhananjay PalMitesh PatelDeep KwatraMridul MukherjiKishore CholkarRavinder Earla
- Topics
- Drug Transport and Resistance Mechanisms (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)HIV/AIDS drug development and treatment (5 papers)
- Journals
- Brain ResearchBiochemical and Biophysical Research CommunicationsInternational Journal of Pharmaceutics
- Partner nations
- United States
In The Last Decade
Ramya Krishna Vadlapatla
29 papers receiving 858 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 366
- Oncology 153
- Ophthalmology 143
- Pharmaceutical Science 95
- Cancer Research 93
Countries citing papers authored by Ramya Krishna Vadlapatla
This map shows the geographic impact of Ramya Krishna Vadlapatla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramya Krishna Vadlapatla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramya Krishna Vadlapatla more than expected).
Fields of papers citing papers by Ramya Krishna Vadlapatla
This network shows the impact of papers produced by Ramya Krishna Vadlapatla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramya Krishna Vadlapatla. The network helps show where Ramya Krishna Vadlapatla may publish in the future.
Co-authorship network of co-authors of Ramya Krishna Vadlapatla
This figure shows the co-authorship network connecting the top 25 collaborators of Ramya Krishna Vadlapatla. A scholar is included among the top collaborators of Ramya Krishna Vadlapatla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramya Krishna Vadlapatla. Ramya Krishna Vadlapatla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 12 | |
| 3 | 46 | |
| 4 | 23 | |
| 5 | Ritonavir Inhibits HIF-1α Mediated VEGF Expression in Retinal Pigment Epithelial Cells | 1 |
| 6 | 49 | |
| 7 | 99 | |
| 8 | 33 | |
| 9 | 2 | |
| 10 | 18 | |
| 11 | 24 | |
| 12 | 91 | |
| 13 | 34 | |
| 14 | 28 | |
| 15 | 50 | |
| 16 | 22 | |
| 17 | 41 | |
| 18 | 20 | |
| 19 | 24 | |
| 20 | 35 |
About Ramya Krishna Vadlapatla
Ramya Krishna Vadlapatla is a scholar working on Virology, Biochemistry and Ophthalmology, having authored 29 papers that have together received 878 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Ophthalmology (143 citations), Pharmaceutical Science (95 citations) and Biochemistry (51 citations). Ramya Krishna Vadlapatla has collaborated with scholars based in United States. Frequent co-authors include Aswani Dutt Vadlapudi, Ashim K. Mitra, Dhananjay Pal, Ashim K. Mitra, Ashim K. Mitra, Mitesh Patel, Deep Kwatra, Mridul Mukherji, Kishore Cholkar and Ravinder Earla. Their work appears in journals such as Brain Research, Biochemical and Biophysical Research Communications and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.